000 01121 a2200289 4500
005 20250513154718.0
264 0 _c19990317
008 199903s 0 0 por d
022 _a0066-782X
024 7 _a10.1590/s0066-782x1998000800012
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKaiser, S E
245 0 0 _a[The impact HMG-CoA reductase inhibitors on the modification of the natural history of coronary artery disease].
_h[electronic resource]
260 _bArquivos brasileiros de cardiologia
_cAug 1998
300 _a153-62 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aCoronary Disease
_xprevention & control
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHydroxymethylglutaryl-CoA Reductase Inhibitors
_xtherapeutic use
650 0 4 _aHypercholesterolemia
_xdrug therapy
650 0 4 _aMale
650 0 4 _aPravastatin
_xtherapeutic use
700 1 _ade Alcantara, M L
773 0 _tArquivos brasileiros de cardiologia
_gvol. 71
_gno. 2
_gp. 153-62
856 4 0 _uhttps://doi.org/10.1590/s0066-782x1998000800012
_zAvailable from publisher's website
999 _c9780905
_d9780905